Bruker BRKR
NASDAQ BRKR
$54.85 -3.52 (-6.04%)
As of: Sep 9, 2026 · 12:05 PM EDT

Bruker (BRKR) Income from Continuing Operations (2010 - 2026)

Bruker's (BRKR) quarterly Income from Continuing Operations came in at -$65.2 million in Q2 2026, down 816.48% on a YoY basis from $9.1 million in Q2 2025, and down 605.43% quarter-over-quarter from $12.9 million in Q1 2026.

Analysis

Bruker (BRKR) Income from Continuing Operations (2010 - 2026) Analysis & Trends

Bruker (BRKR) has reported Income from Continuing Operations for 17 consecutive years, with -$65.2 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Income from Continuing Operations fell 816.48% year-over-year to -$65.2 million; the trailing twelve-month figure through Jun 2026 stood at $133.9 million (down 48.46% YoY), and the FY2025 full-year result was $206.2 million, down 31.7% from the prior year.
  • Income from Continuing Operations retreated to -$65.2 million in Q2 2026 per BRKR's latest filing, from $12.9 million in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at $243.9 million in Q4 2025 and bottomed at -$72.1 million in Q1 2024.
  • Historically, Income from Continuing Operations has averaged $49.9 million across 5 years, with a median of $34.2 million in 2022.
  • The sharpest annual moves came in 2025 and 2026: Income from Continuing Operations jumped 137.92% in 2025, then slumped 816.48% in 2026.
  • Over 5 years, Income from Continuing Operations stood at $99.9 million in 2022, then soared by 78.28% to $178.1 million in 2023, then grew by 13.31% to $201.8 million in 2024, then advanced by 20.86% to $243.9 million in 2025, then tumbled by 126.73% to -$65.2 million in 2026.
  • According to Business Quant data, Income from Continuing Operations over the past three periods registered -$65.2 million, $12.9 million, and $243.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Thermo Fisher Scientific 224.92 Bn 220.86 Bn 8.34 Bn 1.76 Bn
2 Danaher 144.28 Bn 139.93 Bn 3.61 Bn 870.00 Mn
3 Agilent Technologies 40.97 Bn 39.21 Bn 1.04 Bn 362.00 Mn
4 Illumina 31.40 Bn 30.23 Bn 770.00 Mn 207.00 Mn
5 Revvity 13.71 Bn 12.68 Bn 416.87 Mn 53.48 Mn
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn 54.62 Mn
7 Bio-Rad Laboratories 10.08 Bn 8.46 Bn 345.80 Mn 371.40 Mn
8 Repligen 9.47 Bn 8.46 Bn 110.04 Mn 5.01 Mn
9 10x Genomics 8.71 Bn 8.16 Bn 112.50 Mn -17.93 Mn
10 Bruker 8.37 Bn 8.16 Bn 416.00 Mn -65.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -65.20 Mn
Mar 31, 2026 12.90 Mn
Dec 31, 2025 243.90 Mn
Sep 30, 2025 -57.70 Mn
Jun 30, 2025 9.10 Mn
Mar 31, 2025 8.40 Mn
Dec 31, 2024 201.80 Mn
Sep 30, 2024 40.50 Mn
Jun 30, 2024 -24.00 Mn
Mar 31, 2024 -72.10 Mn
Dec 31, 2023 178.10 Mn
Sep 30, 2023 88.40 Mn
Jun 30, 2023 38.30 Mn
Mar 31, 2023 47.60 Mn
Dec 31, 2022 99.90 Mn
Sep 30, 2022 88.10 Mn
Jun 30, 2022 30.00 Mn
Mar 31, 2022 30.20 Mn
Dec 31, 2021 84.20 Mn
Sep 30, 2021 88.10 Mn